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Eight moderate early postoperative complications (Clavien grade II–II) and two
severe postoperative complications were reported. Repeated surgery was nec-
essary in 6 patients for anastomotic stenosis (n = 3), peristomial hernia(n = 1),
repeated pyelonephritis(n = 1).
At last follow-up, no renal insufficiency or peristomial urinary leakages were
reported.
Conclusion.– CNCUD is the last resort treatment of neurogenic bladder in spina
bifida patients. Few data are available in the literature concerning adult spina
bifida patients. CNCUD provided upper urinary tract protection without problem
of stomia equipment in this population.
http://dx.doi.org/10.1016/j.rehab.2014.03.307
CO03-006-e
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Objective.– To determine the efficacy of bladder injections of Botox® 300 UI
on symptomatic urinary infections.
Method.– Analysis of a database of patients with NDO, using intermittent
catheterization, regularly treated with 300 IU Botox® between 2002 and 2011.
We studied the rate of patients with symptomatic lower and upper urinary
tract infections before and after the first injection. Urinary tract infections were
defined by the association of urinary tract colonization and clinical signs.
Results.– One hundred and eighty-three patients were included (165 SCI, 18
multiple sclerosis). There was a significant decrease in the number of patients
with symptomatic lower urinary tract infections after the first injection (23.2%
versus 4.3%) and febrile urinary tract infections (27.2% versus 7.1%).
Conclusion.– This study shows the effectiveness of injections (300 IU Botox®)
on the occurrence of symptomatic urinary tract infection in a homogeneous
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The aim of our study is to compare clinical features and urodynamic find-
ings in asymptomatic or symptomatic patients with Lazy Bladder Syndrome
(LBS). We reviewed the charts of 126 adult patients diagnosed with LBS. We
divided patients into 2 groups: asymptomatic and symptomatic patients. After,
we performed a comparative analysis of the data.
The incidence of LBS was significantly higher in women (81%). Twenty-one
patients were asymptomatic (17%), 105 patients were symptomatic (83%). The
patients with symptomatic LBS were significantly older (54.3 years ± 14.7).
Voiding dysfunction (53%) and urinary retention (27%) were the most common
symptoms in symptomatic group. Reduced bladder sensation was revealed no
difference in the 2 groups, but in the symptomatic group, detrusor had also a
poor contractility (P = 0.0001). Nineteen patients (18%) had uro-nephrological
complications.
LBS is certainly underestimated. Voiding dysfunction and urinary retention in
infrequent voiders or uro-nephrological complication (urinary tract infection
with fever, ureteral reflux. . .) should recall LBS diagnosis.
http://dx.doi.org/10.1016/j.rehab.2014.03.309
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Introduction.– The Hinman syndrome or non-neurogenic bladder syndrome is
an uncommon disorder, due to discoordination between the underactive detrusor
muscle and external sphincter (failure of relaxation).It typically occurs in child-
hood but some adult cases have been observed. We present two cases whose
main feature is the adult presentation.
Observations.– Case 1: an 18 year old woman, who had a history of years of
urinary incontinence during her childhood, suffered from an episode of acute
urinary retention. Renal ultrasound was normal and urodynamic study showed
dyssynergic external sphincteric activity during voiding.
Case 2: a 26 year old man, who had suffered from pyelonefritis when he was
a child, complained of difficulty to start voiding for last 8 months. Renal ultra-
sound was normal and urodynamic study showed detrusor acontractility. Uroflow
measurements showed a staccato pattern.
The treatment in both patients consisted of intermittent catheterization to avoid
urinary retention, percutaneous tibial posterior nerve stimulation, myofascial
relaxation and rehabilitation techniques of sphincters with satisfactory results.
Discussion.– The dysfunctional voiding syndrome requires an active treatment
because of potential renal damage. Treatment available nowadays includes
urotherapy, biofeedback, alpha-blockers, botulinum toxin, neuromodulation
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Obstructive Sleep Apnea Syndrome (OSAS) is the most common type of sleep
apnea in general population, especially obese. It is characterized by the repeated
episodes of upper airways obstruction during sleep. OSAS symptoms include:
snoring, irregular breathing during sleep, excessive daytime sleepiness and
sometimes decreased libido. The aim of the study was to assess the prevalence
of weakened sex drive in OSAS patients.
The study was conducted among 183 patients, who were to undergo a scheduled
polysomnography. The survey included questions regarding OSAS symptoms,
quality and length of sleep, sleep breathing disorder and the impairments of
sexual functioning. 168 subjects responded to the question regarding the disturb-
ance of libido in relation to sleep-disordered breathing. Weakened sex drive was
reported by 113 patients (65%): 57.8% men and 74.5% women. Age of patients
affected negatively the sex drive in men, but not in women. There was a positive
correlation between apopnea-hypopnea index with weakened sex drive. OSAS
negatively influenced sex drive. More women were affected by the negative
influence of sleep apnea on sex drive.
http://dx.doi.org/10.1016/j.rehab.2014.03.311
